Exercise Testing in Patients with Pulmonary Hypertension
- PMID: 38337493
- PMCID: PMC10855991
- DOI: 10.3390/jcm13030795
Exercise Testing in Patients with Pulmonary Hypertension
Abstract
Pulmonary hypertension (PH), defined by a mean pulmonary artery pressure of >20 mm Hg, often presents with non-specific symptoms such as dyspnea and exercise intolerance, making it difficult to diagnose early before the onset of right heart dysfunction. Therefore, exercise testing can be of great utility for clinicians who are evaluating patients with an unclear etiology of exercise intolerance by helping identify the underlying mechanisms of their disease. The presence of PH is associated with adverse clinical outcomes, with distinct differences and patterns in the cardiovascular and ventilatory responses to exercise across various PH phenotypes. We discuss the role of exercise-invasive hemodynamic testing, cardiopulmonary exercise testing, and exercise stress echocardiography modalities across the spectrum of PH.
Keywords: cardiopulmonary exercise testing; exercise-induced pulmonary hypertension; heart failure with preserved ejection fraction; hemodynamics; pulmonary hypertension.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Right Heart Adaptation to Exercise in Pulmonary Hypertension: An Invasive Hemodynamic Study.J Card Fail. 2023 Sep;29(9):1261-1272. doi: 10.1016/j.cardfail.2023.04.009. Epub 2023 May 5. J Card Fail. 2023. PMID: 37150503
-
Diagnostic utility of sub-maximum cardiopulmonary exercise testing in the ambulatory setting for heart failure with preserved ejection fraction.Pulm Circ. 2020 Nov 25;10(4):2045894020972273. doi: 10.1177/2045894020972273. eCollection 2020 Oct-Dec. Pulm Circ. 2020. PMID: 33282205 Free PMC article.
-
Pulmonary Vascular Disease and Cardiopulmonary Exercise Testing.Front Physiol. 2020 Aug 5;11:964. doi: 10.3389/fphys.2020.00964. eCollection 2020. Front Physiol. 2020. PMID: 32848882 Free PMC article. Review.
-
Association Between Hemodynamic Markers of Pulmonary Hypertension and Outcomes in Heart Failure With Preserved Ejection Fraction.JAMA Cardiol. 2018 Apr 1;3(4):298-306. doi: 10.1001/jamacardio.2018.0128. JAMA Cardiol. 2018. PMID: 29541759 Free PMC article.
-
Exercise intolerance in heart failure: The important role of pulmonary hypertension.Exp Physiol. 2020 Dec;105(12):1997-2003. doi: 10.1113/EP088105. Epub 2020 Mar 16. Exp Physiol. 2020. PMID: 32092200 Free PMC article. Review.
Cited by
-
[Highlights 57th SEPAR Congress].Open Respir Arch. 2024 Sep 5;6(4):100360. doi: 10.1016/j.opresp.2024.100360. eCollection 2024 Oct-Dec. Open Respir Arch. 2024. PMID: 39351171 Free PMC article. Review. Spanish.
-
Echocardiographic correlation of right ventricular-Pulmonary artery coupling to exercise tolerance in congenital heart disease-associated pulmonary hypertension.Ann Pediatr Cardiol. 2025 Jan-Feb;18(1):26-32. doi: 10.4103/apc.apc_230_24. Epub 2025 Jul 14. Ann Pediatr Cardiol. 2025. PMID: 40814332 Free PMC article.
-
Level 3 Cardiopulmonary Exercise Testing to Guide Therapeutic Decisions in Non-Severe Pulmonary Hypertension with Lung Disease.Life (Basel). 2025 Jul 11;15(7):1089. doi: 10.3390/life15071089. Life (Basel). 2025. PMID: 40724591 Free PMC article.
References
-
- Humbert M., Kovacs G., Hoeper M.M., Badagliacca R., Berger R.M.F., Brida M., Carlsen J., Coats A.J.S., Escribano-Subias P., Ferrari P., et al. ESC/ERS Scientific Document Group. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Heart J. 2022;43:3618–3731. doi: 10.1093/eurheartj/ehac237. - DOI - PubMed
-
- Ho J.E., Zern E.K., Lau E.S., Wooster L., Bailey C.S., Cunningham T., Eisman A.S., Hardin K.M., Farrell R., Sbarbaro J.A., et al. Exercise Pulmonary Hypertension Predicts Clinical Outcomes in Patients With Dyspnea on Effort. J. Am. Coll. Cardiol. 2020;75:17–26. doi: 10.1016/j.jacc.2019.10.048. - DOI - PMC - PubMed
-
- Saggar R., Khanna D., Shapiro S., Furst D.E., Maranian P., Clements P., Abtin F., Dua S., Belperio J., Saggar R. Brief report: Effect of ambrisentan treatment on exercise-induced pulmonary hypertension in systemic sclerosis: A prospective single-center, open-label pilot study. Arthritis Rheum. 2012;64:4072–4077. doi: 10.1002/art.34614. - DOI - PubMed
-
- Malhotra R., Dhakal B.P., Eisman A.S., Pappagianopoulos P.P., Dress A., Weiner R.B., Baggish A.L., Semigran M.J., Lewis G.D. Pulmonary vascular distensibility predicts pulmonary hypertension severity, exercise capacity, and survival in heart failure. Circ. Heart Fail. 2016;9:e003011. doi: 10.1161/CIRCHEARTFAILURE.115.003011. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources